Monocyte chemoattractant protein-1 (MCP-1) is upregulated in renal parenchy
mal cells during kidney disease. To investigate whether MCP-1 promotes tubu
lar and:or glomerular injury, we induced nephrotoxic serum nephritis (NSN)
in MCP-1 genetically deficient mice. Mice were analyzed when tubules and gl
omeruli were severely damaged in the MCP-1-intact strain (day 7). MCP-1 tra
nscripts increased fivefold in MCP-1-intact mice. MCP-1 was predominantly l
ocalized within cortical tubules (90%), and most cortical tubules were dama
ged, whereas few glomerular cells expressed MCP-1 (10%). By comparison, the
re was a marked reduction (>40%) in tubular injury in MCP-1-deficient mice
(histopathology, apoptosis). MCP-1-deficient mice were not protected from g
lomerular injury (histopathology, proteinuria, macrophage influx). Macropha
ge accumulation increased adjacent to tubules in MCP-1-intact mice compared
with MCP-1-deficient mice (70%, P < 0.005), indicating that macrophages re
cruited by MCP-1 induce tubular epithelial cell (TEC) damage. Lipopolysacch
aride-activated bone marrow macrophages released molecules that induced TEC
death that was not dependent on MCP-1 expression by macrophages or TEC. In
conclusion, MCP-1 is predominantly expressed by TEC and not glomeruli, pro
motes TEC and not glomerular damage, and increases activated macrophages ad
jacent to TEC that damage TEC during NSN. Therefore, we suggest that blocka
ge of TEC MCP-1 expression is a therapeutic strategy for some forms of kidn
ey disease.